A proposal for the World Trade Organization to waive intellectual-property rights on pandemic-related pharmaceuticals is still languishing, owing to opposition from rich countries whose companies are reaping monopoly profits. Fortunately, a public-health bill in Brazil points the way to a promising bottom-up solution.

This post was originally published on Common Dreams – Breaking News & Views for the Progressive Community.